Patricks Diagnostic Ltd Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Patricks Diagnostic Ltd Pharmaceutical Import Records from India — 2 Products, $362.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Patricks Diagnostic Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $362.0K Trade | TransData Nexus

Patricks Diagnostic Ltd

Pharmaceutical Importer · Nigeria · Medical Devices & Diagnostics Focus · $362.0K Total Trade · DGFT Verified

Patricks Diagnostic Ltd is a pharmaceutical importer based in Nigeria with a total trade value of $362.0K across 2 products in 1 therapeutic categories. Based on 25 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Patricks Diagnostic Ltd sources from 1 verified Indian supplier, with Reckon Diagnostics Private Limited accounting for 100.0% of imports.

Patricks Diagnostic Ltd — Import Portfolio & Supplier Network

Patricks Diagnostic Ltd import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Patricks Diagnostic Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Reckon Diagnostics Private Limited	$227.3K	19	100.0%

Patricks Diagnostic Ltd sources from 1 verified Indian supplier across 16 distinct formulations. The sourcing is highly concentrated — Reckon Diagnostics Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Diagnostic reagents:widal slide test(Pack size 8x5 ML)	$50.0K	3
Diagnostic reagents :widal (Pack size 8 x 5 ML)	$49.9K	1
Diagnostic kits widal (Pack size8x5 ML	$48.0K	2
Diagnostic kits widal reagent	$21.5K	1
Diagnostic kitswidal test, (pack8 x 5ML)	$17.4K	1
Diagnostic kitswidal reagent	$13.3K	1
Laboratory reagents:crp latex(Pack size 100 test)	$8.4K	1
Diagnostic kitscrp latex, (pack100 test)	$4.9K	1
Diagnostic kitscrp latex (Pack size	$3.7K	1
Laboratory reagents:aso latex (Pack size 100 test)	$2.9K	1
Diagnostic kitsrf latex (Pack size	$2.2K	1
Diagnostic kitsaso latex, (pack100 test)	$2.0K	1
Diagnostic kits:crp latex,Pack size:100	$1.4K	1
Diagnostic kitsaso latex (Pack size	$688	1
Diagnostic kitscrp latex(Pack size	$442	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Diagnostic	Medical Devices & Diagnostics	$216.0K	17	1.2%	10
2	Reagent	Medical Devices & Diagnostics	$146.0K	8	1.1%	15

Patricks Diagnostic Ltd imports 2 pharmaceutical products across 1 categories into Nigeria totaling $362.0K.

Patricks Diagnostic Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Patricks Diagnostic Ltd is a Nigerian company specializing in the importation and distribution of in-vitro diagnostic (IVD) products and medical consumables. Established in 2010, the company is headquartered at 62 Akanro Street, Ilasamaja, Mushin, Lagos State, Nigeria. It was the first company certified by the Medical Laboratory Science Council of Nigeria (MLSCN) in 2014 to import and distribute IVD products and consumables.

The company's mission is to eliminate mediocrity from the healthcare delivery system in Nigeria by providing reliable diagnostic equipment and medical consumables to hospitals, laboratories, and research institutes. Patricks Diagnostic Ltd partners with leading global brands to offer efficient, reliable, durable, and affordable medical, scientific, and laboratory equipment and consumables in the Nigerian and West African healthcare industry.

2Distribution Network

Patricks Diagnostic Ltd operates its distribution network primarily from its headquarters in Lagos State, Nigeria. The company offers same-day delivery services and flexible payment solutions, including extended credit terms, to ensure timely access to medical equipment and consumables for healthcare facilities across Nigeria.

3Industry Role

In Nigeria's pharmaceutical supply chain, Patricks Diagnostic Ltd functions as a primary wholesaler and distributor of in-vitro diagnostic products and medical consumables. By importing finished pharmaceutical formulations from India, the company plays a crucial role in supplying diagnostic equipment and consumables to hospitals, laboratories, and research institutes, thereby enhancing the efficiency and accuracy of medical diagnostics in the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Patricks Diagnostic Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Patricks Diagnostic Ltd's sourcing strategy exhibits a high degree of concentration, with a total import value of $362,000 USD from India over 25 shipments, all sourced from a single supplier, Reckon Diagnostics Private Limited. This single-source dependency may pose risks related to supply chain disruptions, pricing fluctuations, and potential challenges in negotiating favorable terms. The consistent volume of imports from Reckon Diagnostics Private Limited suggests a stable and ongoing relationship, yet the lack of diversification in suppliers could limit the company's ability to mitigate risks associated with supplier-specific issues.

2Supply Chain Resilience

The resilience of Patricks Diagnostic Ltd's supply chain is currently limited due to its reliance on a single supplier, Reckon Diagnostics Private Limited. This dependency increases vulnerability to potential disruptions, such as production delays, quality control issues, or geopolitical factors affecting trade between India and Nigeria. The absence of backup suppliers and limited formulation diversity further exacerbate this risk. Additionally, the company's exposure to specific shipping routes and the regulatory compliance status of Reckon Diagnostics Private Limited are critical factors that influence the overall resilience of the supply chain.

Strategic Implications

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the primary regulatory authority overseeing pharmaceutical imports is the National Agency for Food and Drug Administration and Control (NAFDAC). NAFDAC is responsible for ensuring the safety, efficacy, and quality of drugs and medical devices imported into the country. Key legislation governing pharmaceutical imports includes the National Agency for Food and Drug Administration and Control Act, which outlines the regulatory framework for drug registration, importation, and distribution. The marketing authorization pathway for Indian generics involves obtaining NAFDAC approval, which requires submission of comprehensive documentation, including evidence of Good Manufacturing Practice (GMP) compliance, product samples, and clinical data demonstrating bioequivalence to the innovator product.

2Import Licensing & GMP

Import licensing requirements in Nigeria mandate that all pharmaceutical products, including in-vitro diagnostic devices, must be registered with NAFDAC before importation. Indian exporters seeking to supply Patricks Diagnostic Ltd must ensure that their products are manufactured in facilities certified for Good Manufacturing Practice (GMP), recognized by NAFDAC. GMP certifications from reputable bodies such as the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S) are typically accepted. Additionally, Indian exporters must obtain wholesale distribution authorization from NAFDAC, which involves demonstrating compliance with Nigerian regulatory standards and maintaining appropriate storage and distribution facilities.

Patricks Diagnostic Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Patricks Diagnostic Ltd's focus on in-vitro diagnostic products and medical consumables aligns with the growing demand for accurate and efficient diagnostic tools in Nigeria's healthcare sector. The company's product portfolio includes hematology analyzers, microbiological analyzers, point-of-care testing devices, chemical analyzers, and immunology analyzers, catering to various diagnostic needs in hospitals, laboratories, and research institutes. This strategic focus addresses the critical need for reliable diagnostic equipment to enhance patient care and support medical research in the country.

2Sourcing Profile

Patricks Diagnostic Ltd's sourcing strategy emphasizes the importation of finished pharmaceutical formulations, specifically in-vitro diagnostic devices, from India. This approach leverages India's established reputation for producing high-quality diagnostic products at competitive prices. The company's reliance on a single supplier, Reckon Diagnostics Private Limited, suggests a preference for consistency and reliability in product quality and supply. However, this strategy also highlights the need for diversification to mitigate potential supply chain risks.

3Market Positioning

Seller's Guide — How to Become a Supplier to Patricks Diagnostic Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by offering alternative products and formulations that meet the quality standards required by Patricks Diagnostic Ltd. Diversifying the supplier base could lead to a more resilient supply chain and provide the company with leverage in negotiating terms. Identifying gaps in Patricks Diagnostic Ltd's current sourcing, such as the need for additional product lines or formulations, presents avenues for new suppliers to establish partnerships and expand their market presence in Nigeria.

2Requirements & Qualifications

Indian exporters seeking to supply Patricks Diagnostic Ltd and the Nigerian market must ensure that their products are manufactured in facilities certified for Good Manufacturing Practice (GMP), recognized by NAFDAC. They must obtain NAFDAC registration for each product, which involves submitting comprehensive documentation, including evidence of GMP compliance, product samples, and clinical data demonstrating bioequivalence. Additionally, exporters must secure wholesale distribution authorization from NAFDAC, demonstrating compliance with Nigerian regulatory standards and maintaining appropriate storage and distribution facilities.

How to Approach

Frequently Asked Questions — Patricks Diagnostic Ltd

What products does Patricks Diagnostic Ltd import from India?

Patricks Diagnostic Ltd imports 2 pharmaceutical products across 1 categories. Top imports: Diagnostic ($216.0K), Reagent ($146.0K).

Who supplies pharmaceuticals to Patricks Diagnostic Ltd from India?

Patricks Diagnostic Ltd sources from 1 verified Indian suppliers. The primary supplier is Reckon Diagnostics Private Limited (100.0% of imports, $227.3K).

What is Patricks Diagnostic Ltd's total pharmaceutical import value?

Patricks Diagnostic Ltd's total pharmaceutical import value from India is $362.0K, based on 25 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Patricks Diagnostic Ltd focus on?

Patricks Diagnostic Ltd imports across 1 categories. The largest: Medical Devices & Diagnostics (100.0%).

Get Full Patricks Diagnostic Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.